Knockdown of SPRY4-IT1 has been shown to reduce proliferation, migration and invasiveness of melanoma cells (Khaitan et al., 2011) and alter a lipid metabolism, leading to cellular lipotoxicity and induction of apoptosis (Mazar et al., 2014). Here, SPRY4 is linked to melanoma.